Atlas Trials

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Clinical trial NCT02533700 · UNKNOWN

Trial details

NCT number
NCT02533700
Sponsor
Shandong Provincial Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell LymphomaEnteropathy Associated T Cell LymphomaSubcutaneous Panniculitis Like T Cell LymphomaHepatosplenic T-cell Lymphoma
Start date
2015-09-01
Primary completion
2019-05-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.